Cargando…
Methylene blue for intractable pain from oral mucositis related to cancer treatment: a randomized phase 2 clinical trial
BACKGROUND: Oral mucositis (OM) in patients receiving cancer therapy is thus far not well managed with standard approaches. We aimed to assess the safety and effectiveness of methylene blue (MB) oral rinse for OM pain in patients receiving cancer therapy. METHODS: In this randomized, single-blind ph...
Autores principales: | Roldan, Carlos J., Huh, Billy, Song, Juhee, Nieto, Yago, Osei, Joyce, Chai, Thomas, Nouri, Kent, Koyyalagunta, Lakshmi, Bruera, Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632023/ https://www.ncbi.nlm.nih.gov/pubmed/36324139 http://dx.doi.org/10.1186/s12916-022-02579-8 |
Ejemplares similares
-
Methylene Blue for the Treatment of Radiation-Induced Oral Mucositis during Head and Neck Cancer Treatment: An Uncontrolled Cohort
por: Roldan, Carlos J., et al.
Publicado: (2023) -
Long-term follow-up of intradermal injection of methylene blue for intractable, idiopathic pruritus ani
por: Kim, J. H., et al.
Publicado: (2019) -
Methylene Blue: Revisited
por: Ginimuge, Prashant R., et al.
Publicado: (2010) -
Methylene-Blue in Fevers
por: Frost, G. H.
Publicado: (1908) -
Removal of Methylene Blue from a synthetic effluent by ionic flocculation
por: Teixeira, Yago Neco, et al.
Publicado: (2022)